Drug Profile
Pateclizumab
Alternative Names: Anti-LT alpha; MLTA 3698 A; PRO 283698; RG 7416Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Genentech
- Class Antirheumatics; Monoclonal antibodies
- Mechanism of Action Lymphotoxin alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 23 May 2013 Genetech completes a phase II trial in Rheumatoid Arthritis in the US, Bulgaria, Chile, Germany, Hungary, Mexico, Spain, Peru, Poland and Romania (NCT01225393)
- 30 Jan 2013 Discontinued - Phase-I for Rheumatoid arthritis in Hungary (IV)
- 30 Jan 2013 Discontinued - Phase-I for Rheumatoid arthritis in Hungary (SC)